U.S. markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
16.70-0.30 (-1.76%)
Al cierre: 04:00PM EDT
16.80 +0.10 (+0.60%)
Fuera de horario: 07:32PM EDT

Elanco Animal Health Incorporated

2500 Innovation Way
Greenfield, IN 46140
United States
877 352 6261
https://www.elanco.com

Sector(es)Healthcare
IndustriaDrug Manufacturers - Specialty & Generic
Empleados a tiempo completo9,300

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Jeffrey N. SimmonsPresident, CEO & Director2.46MN/D1967
Mr. Todd S. Young J.D.Executive VP & CFO1.11MN/D1972
Dr. Ramiro Martin CabralExecutive Vice President of Elanco International950.74kN/D1972
Dr. Ellen de Brabander Ph.D.Executive Vice President of Innovation, Regulatory & Business Development1.14MN/D1963
Mr. Timothy J. BettingtonExecutive Vice President of Corporate Strategy & Market Development1.19MN/D1974
Mr. James M. MeerSenior VP & Chief Accounting OfficerN/DN/D1970
Mr. Chris KeeleySenior VP & Chief Information OfficerN/DN/DN/D
Mr. David S. KinardExecutive Vice President of Human Resources, Corporate Communications & Administration722.58kN/D1967
Katy GrissomHead of Investor RelationsN/DN/DN/D
Ms. Shiv O'NeillExecutive Vice President, General Counsel & Corporate SecretaryN/DN/D1974
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Gestión corporativa

La calificación ISS Governance QuickScore de Elanco Animal Health Incorporated a partir del 1 de mayo de 2024 es 7. Las puntuaciones principales son Auditoría: 8; Junta: 8; Derechos del accionista: 7; Compensación: 5.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.